Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Relevance of in vitro antimicrobial susceptibility of Brucella melitensis to relapse rate in human brucellosis.

Literature DB >> 3813520

Relevance of in vitro antimicrobial susceptibility of Brucella melitensis to relapse rate in human brucellosis.

J Ariza, J Bosch, F Gudiol, J Liñares, P F Viladrich, R Martín.

Abstract

The in vitro susceptibility of Brucella melitensis was examined vis-a-vis the clinical outcome in 75 patients with brucellosis. The initial MICs for Brucella isolates from patients who relapsed and from those who did not were similar. Furthermore, the MICs for isolates from patients whose infections relapsed were no different from those for original isolates. Our results clearly showed that neither initial nor subsequent antibiotic susceptibility plays a role in the likelihood of relapse of patients with brucellosis.

Entities: Disease Species

Mesh：

Substances：

Year: 1986 PMID： 3813520 PMCID： PMC180631 DOI： 10.1128/AAC.30.6.958

Source DB: PubMed Journal: Antimicrob Agents Chemother ISSN： 0066-4804 Impact factor: 5.191

28 in total

1. [Relation between complement fixation and incomplete antibodies (Coombs' test) in human brucellosis].

Authors: A FOZ; S GARRIGA
Journal: Rev Immunol Ther Antimicrob Date: 1954

2. Laboratory diagnosis of brucellosis in man.

Authors: M RUIZ CASTANEDA
Journal: Bull World Health Organ Date: 1961 Impact factor: 9.408

3. The protection of intracellular brucella against streptomycin alone and in combination with other antibiotics.

Authors: R L MAGOFFIN; W W SPINK
Journal: J Lab Clin Med Date: 1951-06

4. Effect of rifampin on nasal carriage of Staphylococcus aureus.

Authors: M A Sande; G L Mandell
Journal: Antimicrob Agents Chemother Date: 1975-03 Impact factor: 5.191

5. The rose bengal plate agglutination test in the diagnosis of brucellosis.

Authors: W J Morgan; D J MacKinnon; J R Lawson; G A Cullen
Journal: Vet Rec Date: 1969-12-06 Impact factor: 2.695

6. Determination of the in vitro sensitivity of Brucella strains to rifampicin.

Authors: M J Corbel
Journal: Br Vet J Date: 1976 May-Jun

Review 7. Brucellosis in the United States, 1960-1972. An abattoir-associated disease. Part I. Clinical features and therapy.

Authors: T M Buchanan; L C Faber; R A Feldman
Journal: Medicine (Baltimore) Date: 1974-11 Impact factor: 1.889

8. In vitro susceptibility of Brucella to various antibiotics.

Authors: W H Hall; R E Manion
Journal: Appl Microbiol Date: 1970-10

9. Intracellular production of Brucella L forms . II. Induction and survival of Brucella abortus L forms in tissue culture.

Authors: B A Hatten; S E Sulkin
Journal: J Bacteriol Date: 1966-01 Impact factor: 3.490

10. Follow-up study of therapy in forty-eight culturally proved cases of brucellosis; streptomycin and sulfadiazine, aureomycin, and chloramphenicol (chloromycetin).

Authors: W W SPINK; W H HALL; R MAGOFFIN
Journal: AMA Arch Intern Med Date: 1951-10

9 in total

1. Comparison of E test to microdilution for determining in vitro activities of antibiotics against Brucella melitensis.

Authors: D Gür; S Kocagöz; M Akova; S Unal
Journal: Antimicrob Agents Chemother Date: 1999-09 Impact factor: 5.191

2. Multicenter prospective study of treatment of Brucella melitensis brucellosis with doxycycline for 6 weeks plus streptomycin for 2 weeks.

Authors: J M Cisneros; P Viciana; J Colmenero; J Pachón; C Martinez; A Alarcón
Journal: Antimicrob Agents Chemother Date: 1990-05 Impact factor: 5.191

Relevance of in vitro antimicrobial susceptibility of Brucella melitensis to relapse rate in human brucellosis.

1. [Relation between complement fixation and incomplete antibodies (Coombs' test) in human brucellosis].

2. Laboratory diagnosis of brucellosis in man.

3. The protection of intracellular brucella against streptomycin alone and in combination with other antibiotics.

4. Effect of rifampin on nasal carriage of Staphylococcus aureus.

5. The rose bengal plate agglutination test in the diagnosis of brucellosis.

6. Determination of the in vitro sensitivity of Brucella strains to rifampicin.

Review 7. Brucellosis in the United States, 1960-1972. An abattoir-associated disease. Part I. Clinical features and therapy.

8. In vitro susceptibility of Brucella to various antibiotics.

9. Intracellular production of Brucella L forms . II. Induction and survival of Brucella abortus L forms in tissue culture.

10. Follow-up study of therapy in forty-eight culturally proved cases of brucellosis; streptomycin and sulfadiazine, aureomycin, and chloramphenicol (chloromycetin).

1. Comparison of E test to microdilution for determining in vitro activities of antibiotics against Brucella melitensis.

2. Multicenter prospective study of treatment of Brucella melitensis brucellosis with doxycycline for 6 weeks plus streptomycin for 2 weeks.

Review 3. The current therapeutical strategies in human brucellosis.

4. Brain abscess caused by Brucella abortus and Staphylococcus aureus in a child.

5. In vitro susceptibility of Brucella melitensis to antibiotics.

6. Effect of carbon dioxide on broth microdilution susceptibility testing of Brucella spp.

7. Brucella melitensis Wzm/Wzt System: Changes in the Bacterial Envelope Lead to Improved Rev1Δwzm Vaccine Properties.

8. Antibiotic persistence of intracellular Brucella abortus.

9. In vitro synergistic activity of antibiotic combinations against Brucella melitensis using E-test methodology.